Indian Generics, 2008-2012: The Growing Threat to Westernised Markets

Published by: Spectra Intelligence

Published: Jan. 1, 2008 - 138 Pages

Table of Contents

Executive Summary

1. INTRODUCTION TO THE INDIAN PHARMACEUTICAL INDUSTRY

1.0 A Brief History

1.1 The First Companies

1.2 Government Measures to Encourage the Industry

1.2.1 Patents

1.2.2 Price Controls

1.2.3 Government Incentives

1.3 Leading Companies

1.3.1 The Top Ten Indian Pharmaceutical Companies in 2007

1.4 Changes in National Pharmaceutical Export-Import Ratios

1.4.1 The Shift from Active Pharmaceutical Ingredients to Formulations

1.5 The Medium-to-Small Players

1.6 Overseas Presence in the Indian Market

1.6.1 Multinational Branded Companies

1.6.2 Generic Companies

2. GROWTH OF THE INDIAN GENERICS INDUSTRY

2.0 History of the Indian Generics Industry

2.1 Origins - How did it all Start?

2.1.1 The Ladder to Success

2.2 Reverse Engineering

2.3 Speed to Market

2.4 Branded Generics - The Indian Way

2.5 Growth Strategies and Drivers

2.5.1 Active Pharmaceutical Ingredients

2.5.2 Contract Manufacture of Formulations

2.5.3 Own Registrations Abroad

2.5.4 Patent Challenges

2.5.5 Subsidiaries/Joint-Ventures

2.5.6 Acquisitions - The Rationale

2.5.6.1 Recent Acquisitions

3. INDIAN DRUG LEGISLATION

3.0 Legislative Background

3.1 The Drugs and Cosmetics Act, 1940

3.2 Drug Policy of 1986

3.3 Liberalisation Since 1991

3.4 Pharmaceutical Registration

3.5 Data Exclusivity

3.6 Barriers to Foreign Ownership

3.7 Price Controls

3.8 Patents and Intellectual Property

3.8.1 Indian Patents Third Amendment Bill, 2005

3.8.2 Trade-Related Intellectual Property Rights (TRIPS)

3.8.3 Doha Declaration

3.8.4 Impact on International Relations

3.9 Export Incentives

4. THE INDIAN DRUG MARKET

4.0 Domestic Market and Healthcare System

4.1 Market Size and Drivers of Growth

4.1.1 Market Size

4.1.2 Growth Drivers

4.1.2.1 Increased Prosperity and Life Expectancy

4.1.2.2 Improving Transport

4.1.2.3 Healthcare Expenditure

4.2 Leading Domestic Companies

4.3 Leading Foreign Players

4.4 The Indian Market in an International Context

4.5 Market Growth - Past and Future

4.6 The Healthcare System

4.6.1 Basic Healthcare

4.6.2 Hospitals

4.6.3 Health Insurance

4.6.3.1 Social Health Insurance

4.6.3.2 Private Health Insurance

4.6.4 The Poor

4.7 Traditional, Herbal and Ayurvedic Medicines

4.8 Factors Influencing Pricing

5. COMPANY PROFILES

5.1 [Company]

5.1.1 History

5.1.2 Sales Growth

5.1.3 Major Products

5.1.4 Overseas Presence

5.1.4.1 United States

5.1.4.2 Europe

5.2 [Company]

5.2.1 History

5.2.2 Sales Growth

5.2.3 Major Products

5.2.4 Overseas Presence

5.3 [Company]

5.3.1 History

5.3.2 Sales Growth

5.3.3 Major Products

5.3.4 Overseas Presence

5.4 [Company]

5.4.1 History

5.4.2 Sales Growth

5.4.3 Major Products

5.4.4 Overseas Presence

5.5 [Company]

5.5.1 History

5.5.2 Sales Growth

5.5.3 Major Products

5.5.4 Overseas Presence

5.6 [Company]

5.6.1 History

5.6.2 Sales Growth

5.6.3 Major Products

5.6.4 Overseas Presence

5.7 [Company]

5.7.1 History

5.7.2 Sales Growth

5.7.3 Major Products

5.7.4 Overseas Presence

5.8 [Company]

5.8.1 History

5.8.2 Sales Growth

5.8.3 Major Products

5.8.4 Overseas Presence

5.9 [Company]

5.9.1 History

5.9.2 Sales Growth

5.9.3 Major Products

5.9.4 Overseas Presence

5.10 [Company]

5.10.1 History

5.10.2 Sales Growth

5.10.3 Major Products

5.10.4 Overseas Presence

6. OUTLOOK FOR THE INDIAN GENERICS INDUSTRY

6.1 Growth Opportunities and Possible Threats for Indian Companies

6.1.1 Opportunities

6.1.3 Acquisitions

6.2 Threats

6.2.1 Market Saturation and Consolidation

6.2.2 Competition

6.3 Research and Development

6.3.1 New Developments

6.3.2 Alliances

7. CONCLUSIONS AND INSIGHTS FOR THE INDIAN GENERICS MARKET

7.1 Is India the Pharmaceutical Giant of the Future?

7.1.1 Domestic Market

7.1.2 International Growth

7.1.3 Environmental Concerns

7.1.4 Growth through Consolidation

7.1.5 Growth through New Products

7.1.5.1 Generics

7.1.5.2 New Chemical Entities

7.2 Are Indian Companies Allies or Opponents?

7.2.1 Alliances

7.2.2 Indian Companies as Competitors

7.3 Who will be Tomorrow’s Generic Champions?

7.3.1 The Future

List of Tables

Table 1 Presence of Asian Pharmaceutical Companies at Annual Global Exhibitions, 1997-2005

Table 1.1 Pricing Differentials of Ciprofloxacin (10 × 500mg tablets) in 2006

Table 1.2 Price Comparisons of Doxycycline in Europe, the US, and India

Table 1.3 Top Ten Indian Pharmaceutical Companies by Turnover, 2005

Table 1.4 Annual Revenues of the Leading Indian Drug Manufacturers, 2006-2007

Table 1.5 Value Growth Trends of Drug Exports and Imports in India, 1999-2005 (Crore Rupees)

Table 1.6 Domestic Sales of Medium-to-Small Sized Pharmaceutical Players (to March 2005)

Table 1.7 Members of the Organisation of Pharmaceutical Producers of India

Table 2.1 List of Brand Names for Cephalexin, the Manufacturers and Price Comparisons

Table 2.2 Sales Distributions (%) of Selected Indian Drug Manufacturers by Region, 2006

Table 2.3 Ranbaxy Cases and Outcomes with Pfizer in Europe, 2005-2007

Table 2.4 Selected Indian Drug Company Acquisitions in North America

Table 2.5 Selected Indian Drug Company Acquisitions in Western Europe

Table 2.6 Selected Indian Drug Company Acquisitions in Eastern Europe

Table 3.1 Indian Trade Balance, 2000-2007 (US$m)

Table 3.2 Comparison of Indian Data Exclusivity Proposals to Actual Practice in the West

Table 3.3 History of the Indian Patent System

Table 4.1 Analysis of Pharmaceutical Sales in India, Quarter ending March 2007

Table 4.2 Indices of Population and Economic Growth in India, 2004-2008

Table 4.3 Leading Indian Pharmaceutical Company Market Shares, 2004-2006

Table 4.4 Comparison of Indian Drug Sales by Value (US$m) with Key International Territories (2005-2006) and Population Statistics

Table 5.1 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.2 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.3 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.4 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.5 Major [Company] Brands and Sales (Rs and US$ million)

Table 5.6 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.7 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.8 [Company] Major Domestic Brands and Sales (Rps million), 2006-2007

Table 5.9 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.10 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Table 5.11 Annual Sales Figures (Rs and US$) for [Company], 2002-2006

Table 5.12 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.